Almudena Cecilia-Matilla

Dr. Almudena Cecilia-Matilla

Diabetic Foot Unit - Vascular Surgery Service, Hospital Universitario Ramón y Cajal, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Montserrat Fernández-GuarinoMontserrat Fernández-Guarino
Montserrat Fernández-Guarino
Stefano BacciStefano Bacci
Stefano Bacci
LPLuis Alfonso Pérez-González
Luis Alfonso Pérez-González
MMMARIANO BERMEJO MARTÍNEZ
MARIANO BERMEJO MARTÍNEZ
ACAlmudena Cecilia-Matilla
Almudena Cecilia-Matilla
MHMaria Luisa Luisa Hernandez-Bule
Maria Luisa Luisa Hernandez-Bule
Wound healing (WH) is a complex multistep process in which a failure could lead to a chronic wound (CW). CW is a major health problem and includes leg venous ulcers, diabetic foot ulcers, and pressure ulcers. CW is difficult to treat and affects vulnerable and pluripathological patients. On the other hand, excessive scarring leads to keloids and hypertrophic scars causing disfiguration and sometimes itchiness and pain. Treatment of WH includes the cleaning and careful handling of injured tissue, early treatment and prevention of infection, and promotion of healing. Treatment of underlying conditions and the use of special dressings promote healing. The patient at risk and risk areas should avoid injury as much as possible. This review aims to summarize the role of physical therapies as complementary treatments in WH and scarring. The article proposes a translational view, opening the opportunity to develop these therapies in an optimal way in clinical management, as many of them are emerging. The role of laser, photobiomodulation, photodynamic therapy, electrical stimulation, ultrasound therapy, and others are highlighted in a practical and comprehensive approach.
1

20 August 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
Alvaro-Afonso Francisco JavierAlvaro-Afonso Francisco Javier
Alvaro-Afonso Francisco Javier
Yolanda García ÁlvarezYolanda García Álvarez
Yolanda García Álvarez
Esther García-MoralesEsther García-Morales
Esther García-Morales
SFSebastián Flores-Escobar
Sebastián Flores-Escobar
LBLuis De Benito-Fernández
Luis De Benito-Fernández
José Luis Lázaro-MartínezJosé Luis Lázaro-Martínez
José Luis Lázaro-Martínez
Background/Objectives: To analyze the best noninvasive tests prognosis marker in patients with diabetic foot ulcer (DFU) who underwent endovascular revascularization based on clinical outcomes, such as healing rate, time to heal, and free amputation survival after at least a six-month follow-up. Methods: A multicentric prospective observational study was performed with 28 participants with ischemic or neuroischemic DFU who came to the participant centers and underwent endovascular revascularization between January 2022 and March 2023. Toe systolic pressure (TP), ankle systolic pressure (AP), the ankle brachial pressure index (ABPI), the toe brachial pressure index (TBPI), transcutaneous pressure of oxygen (TcPO2), and skin perfusion pressure (SPP) were evaluated using PeriFlux 6000 System, Perimed, Sweden, before (Visit 0) and four weeks after revascularization (Visit 1). The primary clinical outcome was an evaluation of the clinical evolution of noninvasive tests comparing Visit 0 and Visit 1, estimating the sensitivity for predicting wound healing of noninvasive tests at six months following initial recruitment. Results: After six months, 71.43% (n = 20) of DFU healed, four patients (14.3%) received major amputations, and one (3.5%) died. The two tests that best predicted wound healing after revascularization according to the ROC curve were TcPO2 and TP with sensitivities of 0.89 and 0.70 for the cut-off points of 24 mmHg and 46 mmHg, respectively. Conclusions: TcPO2 and TP were the two tests that best predicted wound healing in patients who underwent endovascular revascularization. Clinicians should consider the importance of the evaluation of microcirculation in the healing prognosis of patients with diabetic foot ulcers.
1

Verified
Journal Article
Open access
PDF file
ETElena Toledano-Macías
Elena Toledano-Macías
MMMaría Antonia Martínez
María Antonia Martínez
ACAlmudena Cecilia-Matilla
Almudena Cecilia-Matilla
MMMARIANO BERMEJO MARTÍNEZ
MARIANO BERMEJO MARTÍNEZ
LPLuis Alfonso Pérez-González
Luis Alfonso Pérez-González
MHMaria Luisa Luisa Hernandez-Bule
Maria Luisa Luisa Hernandez-Bule
Keratinocytes play an essential role in the inflammatory phase of wound regeneration. In addition to migrating and proliferating for tissue regeneration, they produce a large amount of cytokines that modulate the inflammatory process. Previous studies have shown that subthermal treatment with radiofrequency (RF) currents used in capacitive resistive electric transfer (CRET) therapy promotes the proliferation of HaCat keratinocytes and modulates their cytokine production. Although physical therapies have been shown to have anti-inflammatory effects in a variety of experimental models and in patients, knowledge of the biological basis of these effects is still limited. The aim of this study was to investigate the effect of CRET on keratinocyte proliferation, cytokine production (IL-8, MCP-1, RANTES, IL-6, IL-11), TNF-α secretion, and the expression of MMP9, MMP1, NF-κB, ERK1/2, and EGFR. Human keratinocytes (HaCat) were treated with an intermittent 448 kHz electric current (CRET signal) in subthermal conditions and for different periods of time. Cell proliferation was analyzed by XTT assay, cytokine and TNF-α production by ELISA, NF-κB expression and activation by immunofluorescence, and MMP9, MMP1, ERK1/2, and EGF receptor expression and activation by immunoblot. Compared to a control, CRET increases keratinocyte proliferation, increases the transient release of MCP-1, TNF-α, and IL-6 while decreasing IL-8. In addition, it modifies the expression of MMPs and activates EGFR, NF-κB, and ERK1/2 proteins. Our results indicate that CRET reasonably modifies cytokine production through the EGF receptor and the ERK1/2/NF-κB pathway, ultimately modulating the inflammatory response of human keratinocytes.